PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 11 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $7,664,000,000 | -2.3% | 11,000,000 | 0.0% | 0.11% | -32.5% |
| Q2 2016 | $7,844,000,000 | -2.2% | 11,000,000 | 0.0% | 0.17% | +15.0% |
| Q1 2016 | $8,021,000,000 | -0.6% | 11,000,000 | 0.0% | 0.15% | +8.1% |
| Q4 2015 | $8,070,000,000 | +8.6% | 11,000,000 | +10.0% | 0.14% | -9.9% |
| Q3 2015 | $7,430,000,000 | -6.3% | 10,000,000 | 0.0% | 0.15% | +9.4% |
| Q2 2015 | $7,929,000,000 | -8.0% | 10,000,000 | -9.1% | 0.14% | -25.0% |
| Q1 2015 | $8,619,000,000 | -0.2% | 11,000,000 | 0.0% | 0.18% | +22.7% |
| Q4 2014 | $8,635,000,000 | – | 11,000,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 8,100,000 | $8,262,000 | 3.45% |
| DAFNA Capital Management LLC | 2,500,000 | $1,775,000 | 1.58% |
| Mohican Financial Management, LLC | 1,500,000 | $1,032,000 | 0.88% |
| Camber Capital Management LP | 9,000,000 | $6,075,000 | 0.39% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 40,144,000 | $27,624,000 | 0.21% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,000,000 | $8,070,000,000 | 0.14% |
| ANGELO GORDON & CO., L.P. | 2,500,000 | $1,720,000 | 0.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,977,000 | $5,008,000 | 0.11% |
| Baker Brothers Advisors | 3,423,000 | $2,375,000 | 0.02% |
| FEDERATED HERMES, INC. | 5,330,000 | $3,852,000 | 0.01% |